Consensus DexCom, Inc.

Stocks

DXCM

US2521311074

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 07:02:03 16/10/2026 pm IST			5-day change	1st Jan Change
88.10 ^USD	+0.45%		+3.91%	+32.15%

04:38pm	HEALTH ROUNDS-Glucose monitoring devices for type 2 diabetes benefit even those not on insulin	RE
15/10	DexCom, Inc. Announces Publication Of CONNECT Study Results For Dexcom G7 In The New England Journal Of Medicine	CI

Evolution of the Average Target: DexCom, Inc.

Evolution of the Target Price: DexCom, Inc.

Changes in Analyst Recommendations: DexCom, Inc.

788f0439b2a7cdd2d9372.lBb0SNtTe1p5HPg3n7d00nAf1UGcUMb187PZ4ugvOvQ.7UzBHukLHDsMTpZNyYMCux104XGuY7yFpcPstrlISIzcV5U6nyESEjUxnw~85a44ba852e7a395831194493b876476

Analysts' recommendations: DexCom, Inc.

13/10	Mizuho Adjusts Price Target on DexCom to $100 From $95	MT
12/10	BTIG Adjusts Price Target on DexCom to $96 From $90	MT
07/10	Evercore ISI Adjusts Price Target on DexCom to $110 From $90	MT
01/10	RBC Raises Price Target on DexCom to $105 From $90, Keeps Outperform Rating	MT
17/09	Truist Securities Adjusts DexCom Price Target to $102 From $93, Maintains Buy Rating	MT
13/08	Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating	MT
04/08	Argus Adjusts Price Target on DexCom to $96 From $86, Maintains Buy Rating	MT
03/08	UBS Adjusts Price Target on DexCom to $102 From $96, Maintains Buy Rating	MT
03/08	Rothschild & Co Redburn Adjusts Price Target on DexCom to $100 From $90, Maintains Buy Rating	MT
31/07	DexCom Glucose Monitors' National Coverage Could Support H2 Upside, RBC Capital Markets Says	MT
31/07	Leerink Partners Adjusts Price Target on DexCom to $94 From $80, Maintains Outperform Rating	MT
31/07	RBC Raises Price Target on DexCom to $90 From $85, Keeps Outperform Rating	MT
31/07	Canaccord Genuity Adjusts Price Target on DexCom to $90 From $82, Maintains Buy Rating	MT
31/07	Evercore ISI Adjusts Price Target on DexCom to $100 From $90, Maintains Outperform Rating	MT
31/07	Mizuho Adjusts Price Target on DexCom to $95 From $90, Maintains Outperform Rating	MT
31/07	Benchmark Adjusts Price Target on DexCom to $82 From $77, Maintains Buy Rating	MT
31/07	Bernstein Adjusts Price Target on DexCom to $90 From $77, Maintains Outperform Rating	MT
31/07	Deutsche Bank Adjusts DexCom Price Target to $92 From $86, Maintains Buy Rating	MT
31/07	Truist Raises Price Target on DexCom to $93 From $87, Keeps Buy Rating	MT
31/07	Baird Adjusts Price Target on DexCom to $105 From $80, Maintains Outperform Rating	MT
31/07	JPMorgan Adjusts Price Target on DexCom to $82 From $65, Maintains Neutral Rating	MT
31/07	Piper Sandler Adjusts Price Target on DexCom to $95 From $88, Maintains Overweight Rating	MT
31/07	Wells Fargo Adjusts Price Target on DexCom to $90 From $85, Maintains Overweight Rating	MT
31/07	Stifel Adjusts Price Target on DexCom to $95 From $90, Maintains Buy Rating	MT
31/07	Citigroup Adjusts Price Target on DexCom to $88 From $84, Maintains Buy Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	DEXCOM, INC.					+9.98%
	ABBOTT LABORATORIES					+15.32%
	MEDTRONIC PLC					+9.38%
	STRYKER CORPORATION					+23.66%
	ESSILORLUXOTTICA					+50.61%
	CENCORA, INC.					+8.42%
	HOYA CORPORATION					+21.02%
	BECTON, DICKINSON AND COMPANY					+0.16%
	IDEXX LABORATORIES, INC.					+28.17%
	MEDLINE INC.					+21.47%
	Average					+18.82%
	Weighted average by Cap.					+18.68%